The Wall Street Journal Real Time Economics Blog highlights the financial impact of The Green House model on slowing the cost increase of dementia care.
A recent article in McKnight’s Long Term Care magazine highlights a study that concludes it is safe in most cases to eliminate antipsychotic drugs.
Three years ago, Kennard Lehmann walked out of a neurologist’s office in Sacramento, Calif., newly diagnosed with early-stage Alzheimer’s disease, a prescription in hand and absolutely no idea where to turn for help.
The doctor hadn’t given him a list of resources or discussed how Mr. Lehmann might go about finding them. Knowing nothing about Alzheimer’s, his wife swiped a magazine she had been reading in the doctor’s office to take home and read.
Thus began a journey all too familiar to people with Alzheimer’s — one that Mr. Lehmann, 75, describes as “being put in a box.”
Is it possible Alzheimer’s is the result of progressive vascular disease as a consequence of aging, and therefore curing Alzheimer’s will be as difficult as curing aging?
I generally avoid posting news about the latest food, vitamin, supplement, or lifestyle factor that may or may not affect your risk of dementia, for better or worse.
Several people are hailing this new step in our approach to Alzheimer’s as a possible breakthrough in the making. So why do I not get filled with hope?
Last week, the first of three multi-day events took place in Nashville, TN, focusing on the reduction of anti-psychotic drugs (see Chris Perna’s recent post for the details). This collaboration between The Eden Alternative and the Tennessee Department of Health, Division of Health Care Facilities has the potential to make an important impact in Tennessee, [...]
Amid the roar over off-label use of antipsychotics in nursing homes, a new study from the Journal of Clinical Psychiatry raises some new questions. This study looked at the four most commonly-used atypical antipsychotics in 332 people for up … Continue reading →
A press release issued today by the Tennessee Department of Health states that the Office of Health Care Facilities has secured a CMP grant totaling more than $370,000 to provide training for 749 people including nursing home direct care staff members, state surveyors and managers, State Long-Term Care Ombudsmen and members of the Tennessee Advancing Excellence [...]
I was recently asked if I would be willing to write a blog post about the American Psychiatric Association’s plans to drop the word “dementia” from the 5th edition of their Diagnosis and Statistical Manual of Mental Disorders, due … Continue reading →
In this week’s edition of Dr. Richard Taylor’s influential newsletter Alzheimer’s from the Inside Out, Richard shared the difficult news that in addition to being a leading advocate for and person living with dementia he is now also a person living with a rare and dangerous form of cancer.
I’m back on the blog after a 2-month hiatus. Things got a little crazy there, but I’ve finally had a chance to catch my breath. Since my last post, I’ve had a wonderful trip to Europe, where I facilitated my … Continue reading →
By Barbara Speedling, Quality of Life Specialist In a recent article concerning the sexual abuse of one nursing home resident by another, the failure of the staff to fully recognize the responsibility to supervise and protect residents from harm leads to a tragic outcome. Not only does the victim suffer irreparable damage, but the perpetrator [...]
Set amid the gentle hills and farmlands of central Tennessee, sprawling Nashville attracts millions of visitors each year. The majority come to immerse themselves in music, whether at mainstream showcases like the Country Music Hall of Fame and the Grand Ole Opry, or in the smaller clubs and honky-tonks found not only downtown but also [...]
After months researching the claim that coconut can treat Alzheimer’s disease, I posted a wrap-up report yesterday. Most of the hype comes from anecdotal reports, not careful science. Even the Alzheimer’s Association concludes that the coconut oil assertion is bogus.
There have been concerns raised for several years about the off-label use of antispychotic drugs in people living with various forms of dementia. But things got kicked into high gear last November 30th with HHS Inspector General Daniel Levinson’s report … Continue reading →
I often worry about the time I spend on the computer researching and writing this blog. But I just joined my housemates in the rec room, intending to ride my exercise bike and watch TV with them. My housemates were watching one of the endless “amateur…
I just discovered a great resource for caregivers of people with Alzheimer’s disease. This group is a private Facebook group where caregivers and patients come together to support, encourage an educate each other in a private environment. The gro…
While attending The Green House Project annual conference in Grand Rapids earlier this month I had the pleasure of recording dementia expert Teepa Snow in a keynote session explaining and humanizing the changes to the brain caused by advanced dementia. Learning these insights into how the brain operates brought together several threads ChangingAging has been following regarding the way we think about and treat people living with dementia.
What is the proper stance of the FDA in ensuring that new and innovative drugs are available as soon as possible, while also ensuring that those drugs are reasonably safe and effective? This is the subject of much controversy these … Continue reading →